• Asian Pacific Journal of Cancer Prevention
• /
• 제15권17호
• /
• pp.7453-7457
• /
• 2014

Objective: To observe the efficacy and toxicity of nanoparticle albumin bound paclitaxel (nab-paclitaxel) plus platinum agent (cisplatin or carboplatin) as first line treatment for stage III/IV squamous non-small-cell lung cancer (NSCLC). Methods: Forty chemotherapy naive patients with stage III/IV squamous NSCLC received nab-paclitaxel $125mg/m^2$ on day 1 and day 8, cisplatin $75mg/m^2$ on day 1, carboplatin area under the concentration-time curve of 5 (AUC=5) on day 1. One cycle of treatment was 3 weeks, and at least two were completed in each case. Results: Of the 40 patients who participated in the study, 25 achieved partial responses (PR), 12 reached a stage of stable disease (SD), and 3 suffered progressive disease (PD). The overall response rate (ORR) was 62.5% and the disease control rate (DCR) was 92.5%. Of the 20 patients without surgery or radiotherapy, 10 achieved PR, 7 reached a stage of SD, and 3 PD. The ORR was 50.0% and the DCR was 85.0%. The median progression-free survival time (PFS) of patients without surgery or radiotherapy was 5.0 months. Of the 20 patients receiving surgery or radiotherapy, 15 had PR and 5 p had SD, with an ORR of 75.0% and a DCR of 85.0%. Specifically, the DDP arm demonstrated a significantly higher ORR than the CBP arm (100%vs 54.5%, P<0.05). Common treatment related adverse events were myelosuppression, gastrointestinal response, baldness and neurotoxicity, most of which were grade 1 to 2. Conclusion: Nab-paclitaxel plus platinum agent (cisplatin or carboplatin) is effective as a first-line chemotheraphy for stage III/IV squamous NSCLC, and its adverse effects are tolerable.

• 자원환경지질
• /
• 제18권3호
• /
• pp.225-237
• /
• 1985

Mineralization of Daehwa and Donsan W-Mo deposits can be devided into three distinct depositional stages on the basis of mineral paragenesis and flnid inclusion studies; stage I, deposition of oxides and silicates ; stage II, deposition of base-metal sulfides and sulfosalts with carbonates; stage III, deposition of barren calcite and fluorite. Tungsten, molybdenum and tin mineralization occurred in stage I. Fluid inclusion studies reveal that ore fluid of stage I were homogeneous $H_2O-CO_2$ fluids containing 3.5~14.6 mol % $CO_2$. Minimum temperature and pressure of stage I ore fluids were $240^{\circ}C$ and 500 bars respectively. Salinities of aqueous type I inclusions in minerals of stage I range from 3.7 to 7.6 wt. % equi. NaCl. whereas those of $CO_2$-containing type III inclusions range from 0.3 to 4.4 wt. %. Temperatures of stage II ore fluids range from 200 to $305^{\circ}C$ on the whole and salinities were in the range of 3.2~7.2 wt. %. Homogenization temperatures of fluid inclusions in calcite and fluorite of stage III range from 114 to $186^{\circ}C$ and salinities were in the range of 0.9~4.3 wt. %. Sulfur fugacities during stage II deduced from mineral assemblages and tamperature data from fluid inclusions declined from earlier to later in the range of $10^{-11}{\sim}10^{-18}atm$. Fluid inclusion evidences suggest that the dominance of $CO_2$ in ore fluid during W-Mo mineralization is the characteristic features of Cretaceous W-Mo deposits of central district of Korea compared to those of Kyeongsang basin district.

• Radiation Oncology Journal
• /
• 제11권2호
• /
• pp.369-376
• /
• 1993

1988년 7월부터 1991년 5월까지 계명대학교 의과대학 동산의료원 치료방사선과에서 완치목적으로 고선량율 강내조사장치로 치료한 226명의 자궁경부암 환자를 대상으로 하여 치료후의 실패양상을 관찰하고자 하였다. 대상환자는 전병기에 고르게 분포하고 있으며, 최장 및 평균 추적관찰기간은 각각 60개월, 43개월이었다. 방사선치료는 외부조사를 먼저 시행하였으며, 가능한 단기간내에 강내치료를 시작하였다. 먼저 외부조사로써 대개의 환자에서 4500~6300 cGy를 골반부에 조사하였으며, 병기에 따라서 2700~4500 cGy부터 골반중앙부를 차폐하였다. 강내치료는 A점을 기준으로 전체 조사선량이 최소한 5700~7500 cGy가 되도록 하였으며, 병기별로 A점에 조사된 평균선량은 IB 6700 cGy, IIA 7200 cGy, IIB 7450 cGy, III 7600 cGy, IV 8100 cGy이었다. FIGO 병기에 따른 환자 분포 는 IB 37명 $(16.4\%),$IIA 91명 $(41.3\%),$ IIB 58명 $(25.7\%),$ III 32명 $(13.8\%),$ IV 8명 $(3.5\%)$이었다. 총 재발환자는 226명 중 54명으로 $23.9\%$이었으며, 각 병기별 재발율은 IB $13.5\%,\;IIA\15.4\%,\;IIB\;25.9\%,\;III\;46.9\%,\;IV\;62.5\%$로 병기가 진행됨에 따라서 재발율이 증가하는 것으로 나타났다. 또 재발 부위별 양상은 54명의 재발환자 중 32명에서 골반내 단일재발이었으며, 11명은 골반재발과 원격전이가 동시에 나타났다. 그리고 나머지 11명에서 원격전이만 보였다. 43명의 국소재발의 반이상을 차지한다. 그리고 조사선량과 재발율과의 관계는 초기환자(IA, IIA)에서는 다소 유의하게 보였으나, 진행된 병기의 환자에서는 조사선량이 많았으나 치료실패율이 현저하게 높았다. 따라서 이들 환자들을 효과적으로 치료하기 위하여 단순히 치료선량을 증가시키는 것보다 다른 보조적치료, 즉 약물치료와의 병용치료 등이 절실히 요구되며, 또한 국소재발의 억제가 원격전이를 감소시킬 수 있는 한 방법일 수 있다.

• Journal of the Korean Association of Oral and Maxillofacial Surgeons
• /
• 제35권5호
• /
• pp.316-323
• /
• 2009

Purpose: This study was performed to evaluate three-dimensional positional change of the condyle using 3D CT after bilateral sagittal split ramus osteotomy (BSSRO) in skeletal class III patients. Patients and methods: Nine patients who underwent BSSRO for mandibular set-back in skeletal class III malocclusion without facial asymmetry were examined. Miniplates were used for the fixation after BSSRO. 3-D CT was taken before, immediately after, and 6 months after undergoing BSSRO. After creating 3D-CT images using V-works $4.0^{TM}$ program, axial plane, coronal plane, & sagittal plane were configured. Three dimensional positional change, from each plane to the condyle, of the nine patients was measured before, immediately after, and 6 months after undergoing BSSRO. Results: 1. The mean value of mandibular set-back for nine mandibular prognathism patients was 7.36 mm (${\pm}\;2.42\;mm$). 2. In the axial view, condyle is rotated inward immediately after BSSRO (p < 0.05), comparing with preoperative but outward 6 months after BSSRO comparing with postoperative (p < 0.05). 3. In the axial view, condyle is moved laterally immediately after BSSRO (p < 0.05), comparing with preoperative but regressed 6 months after BSSRO comparing with preoperative (p > 0.05). 4. In the frontal & coronal view, there is changed immediately after and 6 months after BSSRO, comparing with preoperative but no statistical difference. Conclusion: These results indicate that three-dimensional positional change of the condyle in skeletal class III patients is observed lateral displacement & inward rotation immediate after BSSRO, but the condyle in 6 months after BSSRO tends to regress to preoperative position.

• Clinical and Experimental Reproductive Medicine
• /
• 제22권2호
• /
• pp.211-220
• /
• 1995

Though the endometriosis is not always related with infertility, endometriosis causes infertility in some patients. There are many treatment modalities of infertile patients who have endometriosis. In recent years, Assisted Reproductive Technology(ART) have been widely accepted as being a useful tool for the treatment of infertile endometriotic patients. The objective of this study was to evaluate the outcome of ART in infertile endometriotic patients who have been carried out IVF-ET from Jan, 1992 to Dec, 1994 and to compare the results between COH/IUI and IVF-ET in the patients with endometriosis stage I. Tubal disease only patients were grouped(308 patient, 956 cycles) as a control. Endometriosis group was subdivided into 4 groups according to American Fertility Society classification; endometriosis stage I (45 patients, 61 cycles), stage II (26 patients, 39 cycles), stage III (26 pateitns, 37 cycles), stage IV (33 patients, 50 cycles). The outcomes of IVF-ET in endometriosis patients were as follows; The oocyte recovery rates were significantly lower in stage III, IV endometriosis. In case of stage III endometriosis, the fertilization rate was significantly lower than other stages of endometriosis. Clinical pregnancy rates per cycle were not different between the tubal group(22%) and the endometriosis group(25%). According to endometriosis stage, the implantation rate and clinical pregnancy rate were significantly lower in stage IV (5.6%, 16%) compared with other stages (I; 10.0%, 26%, II;9.8%, 31%, III;12.6%, 32%). It suggests that some factor like autoantibodies may inhibit implantation of embryos in stage IV endometriosis. To evaluate the possibility that simply increasing the number of gametes at the site of fertilization might account for pregnancies attributed to IVF-ET, the authors retrospectively analyzed the outcome of couples undergoing IUI during hMG cycles and CC cycles between 1992 and 1994 in the women with endometriosis stage 1. In case of stage I endometriosis, though the COH/IUI group showed lower FSH level and lesser age profile than IVF-ET group, IUI group has resulted in lower pregnancy rates(19.2%) compared with the IVF-ET group(26.2%). In conclusion, endometriotic infertile patients can get comparable pregnancy rates with the tubal factor infertility patients during IVF-ET program. Moreover even in stage I endometriosis, IVF-ET may be an more effective treatment modality than COH/IUI.

• Asian Pacific Journal of Cancer Prevention
• /
• 제15권13호
• /
• pp.5283-5286
• /
• 2014

Stage of cervical cancer may adversely affect the quality of life (QOL) among patients. The objective of this study was to predict the QOL among cervical cancer patients by the stage of their cancer. A cross-sectional study from September 2012 until January 2013 was conducted among cervical cancer patients who completed treatment. All patients completed a interviewer-guided questionnaire comprising four sections: (A) socio-demographic data, (B) medical history, (C) QOL measured by general health status questionnaire (QLQ-30) and (D) cervical cancer specific module CX-24 (EORTC) was used to measured patient's functional, symptom scale and their global health status. Results showed that global health status, emotional functioning and pain score were higher in stage III cervical cancer patients while role functioning was higher in stage I cervical cancer patients. Patients with stage IV cancer have a lower mean score in global health status (adjusted b-22.0, 95 CI% -35.6, -8.49) and emotional functioning (adjusted b -22.5, 95CI% -38.1, -6.69) while stage III had lower mean score in role functioning (adjusted b -14.3, 95CI% -25.4, -3.21) but higher mean score in pain (adjusted b 22.1, 95 CI% 8.56, 35.7). In conclusion, stage III and IV cervical cancers mainly affect the QOL of cervical cancer patients. Focus should be given to these subgroups to help in improving the QOL.

• Toxicological Research
• /
• 제17권4호
• /
• pp.267-272
• /
• 2001

This study was carried out to assess the reproductive toxicity of 2-bromopropane (S-BP) using spermatogenesis stage classification and Sertoli cell indices (SCI).Vehicle control olive oil and 2-BP doses of 125, 250 and 500 mg/kg of body weight were injected in the interaperitoneum of 12 weeks male Sprague-Dawley rats for 28 days respectively of SCI on germ cells including the spermatogonia of stages II-III, Ⅵ,Ⅹ, XII, ⅩIII, and spermatocytes of stages VIII (preleptotene), Ⅹ (leptotene), XII (leptotene), V and Ⅵ (pachytene), and the round spermatids of stage Ⅵ. Considering the process of maturation depletion in spermatonesis, spermatogonia may be the primary target cells of 2-BP toxicity.

• 자원환경지질
• /
• 제19권1호
• /
• pp.57-66
• /
• 1986

The ore deposit of the Ohtani mine is one of representatives of plutonic tungsten-tin veins related genetically to acidic magmatism of Late Cretaceous in the Inner zone of Southwest Japan. Based on macrostructures of vein filling, three major mineralization stages are distinguished by major tectonic breaks. The constituents of ore minerals are scheelite, cassiterite, chalcopyrite, pyrrhotite, sphalerite, with small amounts of cubanite, stannite, galena, native bismuth, bismuthinite, arsenopyrite and pyrite. The relationship between the polymorphic variations of pyrrhotite and the kinds of the associated characteristic of ore mineral, in relation with hypogene mineralization, has been demonstrated. Pyrrhotite of stage I is predominantly of the hexagonal phase (Hpo>Mpo). Pyrrhotite of stage II is mainly of the monoclinic phase ($Hpo{\ll}Mpo$). Pyrrhotite of stage III is a single monoclinic phase ($Hpo{\ll}Mpo$). The compositions of the hexagonal pyrrhotite decrease in Fe content ranging from 47.44 atom % Fe in stage I to 46.88 atom % Fe in stage III.

• Journal of Ginseng Research
• /
• 제19권2호
• /
• pp.171-174
• /
• 1995

Freshly harvested American ginseng (Panax quinquefolium L.) seeds were stratified at two locations over each of three years. Seed development and temperature in the stratification boxes were investigated until the seed was removed 12 months later and direct-seeded in the field. During stratification and seeding (14 months) three embryo stages were identified. In Stage I of 250 days (Sept. to mid-May) embryo length increased from about 0.5 to 1.0 mm: in Stage II of 100 days (mid-May to late Aug. when seeded) length increased to 2.0 mm and in Stage III (late Aug. to late Nov.) length increased to 5.3 mm. Excerpt split width could also be placed in three stages. Changes in embryo length correlated with embryo endosperm length ratio. Insertion compression tests showed that the excerpt softened rapidly in late Stage II and throughout Stage III. The stratification box temperatures at all depths (10, 25 and 50 cm) never exceeded -2$^{\circ}C$ even when the air temperatures dropped to -13$^{\circ}C$ and were, therefore not damaging to the seeds.

• 한국추진공학회지
• /
• 제5권4호
• /
• pp.40-49
• /
• 2001

우주발사체의 아포지 킥 모타에 대한 기초연구를 수행하였다. AKM은 3단형 과학로켓 KSR-III의 3단으로서 개발되었다. 이 고체 모타는 HTPB 계열의 복합제 추진제, 복합재 모타 케이스와 잠입형 노즐을 갖추었다. 고체모타를 체계요구조건에 맞도록 개발하기 위하여 우선 직경 520mm의 완성형을 설계하고 약 60% 크기의 축소형 모타를 먼저 개발, 시험하였다. 축소형 모타의 개발 시험으로 완성형 모타의 개발 타당성을 입증하였다. 2차에 걸친 완성형 지상연소 시험을 수행하였다.